niacinamide has been researched along with genistein in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bustamante, F; Donnet, C; Fischbarg, J; Ortega, M; Reyes, AM; Rivas, CI; Rossi, JP; Vera, JC | 1 |
| Banik, NL; Karmakar, S; Ray, SK; Roy Choudhury, S | 1 |
| Arias, A; Catania, VA; Ceballos, MP; Ciriaci, N; Ghanem, CI; Luquita, MG; Mottino, AD; Rigalli, JP; Ruiz, ML; Villanueva, SS | 1 |
| Abdel-Naim, AB; Badawy, NN; El-Ahwany, E; Khalifa, AE; Liu, AW; Tolba, MF; Youssef, MM; Zada, S | 1 |
| Fu, LY; Kang, YM; Liu, KL; Niu, LG; Qi, J; Su, Q; Sun, N; Xin, GR | 1 |
5 other study(ies) available for niacinamide and genistein
| Article | Year |
|---|---|
Nicotinamide is not a substrate of the facilitative hexose transporter GLUT1.
Topics: 3-O-Methylglucose; Animals; CHO Cells; Cricetinae; Cytochalasin B; Deoxyglucose; Erythrocyte Membrane; Erythrocytes; Flavonoids; Genistein; Glucose Transporter Type 1; Humans; Monosaccharide Transport Proteins; Niacinamide; Protein Binding; Transfection; Transport Vesicles | 2002 |
Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplifi
Topics: Angiogenesis Inducing Agents; Apoptosis; bcl-2-Associated X Protein; Benzenesulfonates; Caspase 3; Cell Cycle; Cell Proliferation; Cell Shape; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Drug Synergism; Flow Cytometry; Gene Amplification; Genistein; Humans; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neuroblastoma; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyridines; Signal Transduction; Sorafenib; Telomerase; Treatment Outcome; Tumor Suppressor Protein p53; Up-Regulation | 2010 |
Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genistein; Humans; Liver Neoplasms; Membrane Transport Proteins; MicroRNAs; Niacinamide; Phenylurea Compounds; Phytoestrogens; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sorafenib; Tumor Cells, Cultured | 2015 |
Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Genistein; Hepatocytes; Humans; Inhibitory Concentration 50; Niacinamide; Phenylurea Compounds; Sorafenib | 2016 |
Genistein Alleviates Oxidative Stress and Inflammation in the Hypothalamic Paraventricular Nucleus by Activating the Sirt1/Nrf2 Pathway in High Salt-Induced Hypertension.
Topics: Animals; Antioxidants; Cardiomegaly; Cytokines; Genistein; Glutathione Disulfide; Hypertension; Inflammation; Male; NF-E2-Related Factor 2; Niacinamide; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Reactive Oxygen Species; Sirtuin 1; Sodium Chloride, Dietary; Superoxide Dismutase | 2022 |